Literature DB >> 3125616

Bactericidal properties of urine for Neisseria gonorrhoeae.

R C Noble1, M C Parekh.   

Abstract

Some human urine is bactericidal for the F-62 strain of Neisseria gonorrhoeae. Gonococci of three auxotypes (Pro-; Arg-, Hyx-, Ura-; and Pro-, Arg-. (Orn*), Ura-) were tested by in-vitro exposure to 31 samples of urine from 14 men. Nineteen of the urine specimens were bactericidal, and 12 were not. Except for one sample, all cidal urines came from five men. Cidal activity was associated with acidic, concentrated urines; it was unaffected by exposure to lowered pH, pronase, heat or cold, and was dialyzable with use of a dialysis membrane with a cut-off molecular weight of 1000. Neutralization of the acid urines removed the antigonococcal activity. Noncidal acid urines became cidal urines when concentrated by lyophilization. Zinc, lysozyme, fluoride ions, and fatty acids are substances that have antibacterial activity and are also present in urine. These substances were examined for antigonococcal activity. Neither zinc salts, fluoride ions, lysozyme, nor fatty acids in concentrations exceeding those found in urine were bactericidal for the gonococci. These results show that sufficiently concentrated, acidic urines kill gonococci by an unknown mechanism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3125616     DOI: 10.1097/00007435-198710000-00009

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  3 in total

Review 1.  Microbiological diagnosis of gonorrhoea.

Authors:  A E Jephcott
Journal:  Genitourin Med       Date:  1997-08

2.  Isolation of Neisseria gonorrheae and concomitant bacterial microflora from urine obtained by suprapubic bladder puncture in women with gonococcal urethritis.

Authors:  J Péc; J Kliment; P Moravcík; I Fetisov; K Pécová
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

3.  Selection of Opa+ Neisseria gonorrhoeae by limited availability of normal human serum.

Authors:  M P Bos; D Hogan; R J Belland
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.